ZA922010B - Improved method of treatment for benign prostatic hyperplasia - Google Patents

Improved method of treatment for benign prostatic hyperplasia

Info

Publication number
ZA922010B
ZA922010B ZA922010A ZA922010A ZA922010B ZA 922010 B ZA922010 B ZA 922010B ZA 922010 A ZA922010 A ZA 922010A ZA 922010 A ZA922010 A ZA 922010A ZA 922010 B ZA922010 B ZA 922010B
Authority
ZA
South Africa
Prior art keywords
treatment
improved method
benign prostatic
prostatic hyperplasia
hyperplasia
Prior art date
Application number
ZA922010A
Inventor
Glenn J Gormley
J Gormley Glenn
Elizabeth Stoner
Stoner Elizabeth
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA922010B publication Critical patent/ZA922010B/en

Links

ZA922010A 1991-03-20 1992-03-19 Improved method of treatment for benign prostatic hyperplasia ZA922010B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67251191A 1991-03-20 1991-03-20

Publications (1)

Publication Number Publication Date
ZA922010B true ZA922010B (en) 1992-11-25

Family

ID=24698859

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922010A ZA922010B (en) 1991-03-20 1992-03-19 Improved method of treatment for benign prostatic hyperplasia

Country Status (2)

Country Link
PT (1) PT100256B (en)
ZA (1) ZA922010B (en)

Also Published As

Publication number Publication date
PT100256A (en) 1993-07-30
PT100256B (en) 1999-06-30

Similar Documents

Publication Publication Date Title
IL101243A0 (en) Pharmaceutical compositions for treatment of benign prostatic hyperplasia
EP0667769A4 (en) Use of alpha-1c specific compounds to treat benign prostatic hyperplasia.
AU6393896A (en) Method for treating benign prostatic hyperplasia with thermal therapy
IL101574A0 (en) Combination pharmaceutical compositions for the treatment of benign prostatic hyperplasia
EP0758196A4 (en) Compositions and methods of treating tumors
ZA952763B (en) Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
AU4407093A (en) Method and apparatus for prostatic treatment
EP0855910A4 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
HU9501286D0 (en) Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
EP0633781A4 (en) Compositions and methods for treating benign prostatic hypertrophy.
ZA922010B (en) Improved method of treatment for benign prostatic hyperplasia
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
AU5457694A (en) Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
EP0733365A3 (en) Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer
ZA936166B (en) Methods of treating cancer
GB9202196D0 (en) Method of treatment
IL122316A0 (en) Melatonin agonists for treating benign prostatic hyperplasia
ZA922810B (en) New combination treatment for benign prostatic hyperplasia
ZA922012B (en) New method of treatment for prostatic cancer
AUPO410796A0 (en) Method of treating benign prostatic hyperplasia
ZA932731B (en) Method of treating gar-transformylase-dependent tumors
EP0705104A4 (en) Method of cancer treatment
GB9810895D0 (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU6374798A (en) Methods and compositions of (+) doxazosin for the treatment of hypertension and benign prostatic hyperplasia
GB9223252D0 (en) Method of treatment